News & Events

April 3, 2012

IntegriChain Announces the Successful Completion of its SOC 2 Examination

AN AUDIT OF INTEGRICHAIN’S PROCEDURES, POLICIES, & STANDARDS PROVIDES CLIENTS ASSURANCE REGARDING DATA SECURITY, AVAILABILITY, & PROCESSES.

Princeton, NJ – April 3, 2012 – IntegriChain Inc., a commercial provider of cloud-based channel data and analytic applications (apps) to the pharmaceutical industry, announced today that it has successfully completed a Service Organization Controls (SOC 2) examination. The examination was performed under AT 101 standards following The American Institute of Certified Public Accountants (AICPA) Trust Services Principles and related criteria covering security, availability, and processing integrity.

ParenteBeard, a top-ranked U.S. accounting firm and independent member of the Baker Tilly International network, performed the examination of IntegriChain’s DNA cloud.

“Over the past five years, IntegriChain has worked to develop the DNA cloud and its accompanying apps into an engine that delivers cutting-edge analytics as well as security and stability,” stated Dennis O’Malley, IntegriChain’s VP of Operations. “We are proud of the auditors’ finding, and feel that our SOC 2 Report reflects the significant progress we have made in developing DNA into the industry’s only channel analytics cloud.”

Kevin Leininger, IntegriChain’s CEO, added, “Nine of the top 15 pharma and biopharma manufacturers’ channel sales are analyzed in the DNA cloud. IntegriChain’s SOC 2 compliance is critical to securing the continued confidence of our customers that DNA meets and exceeds the highest standards for information security and process integrity.”

The DNA SOC 2 Report is available upon direct request to existing IntegriChain customers and to prospective customers who have entered into a Confidentiality and Non-Disclosure Agreement with IntegriChain.

About IntegriChain
IntegriChain, Inc. launched the Demand Network Analytics (DNA) commerce platform in 2007. Today, DNA is helping a growing community of innovative manufacturers realize their vision of a truly demand driven enterprise. DNA’s trade data management and analytic applications optimize hundreds of billions of dollars in annual commerce, helping manufacturers lower their distribution costs, improve sales predictability, and ensure product availability throughout their distribution channels. For more information, please visit www.integrichain.com.

All names referred to are trademarks or registered trademarks of their respecitve owners.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand